Skip to main content
Caplight Logo









Ceres Pharma

Ceres Pharma

Private
BelgiumHealthcare & Life Scienceshttps://ceres-pharma.com/en

Last Round

Corporate Funding

Oct 6, 2022

Company Overview

Ceres Pharma is a pharmaceutical company that develops, produces, and distributes medical products, drugs, food supplements, and cosmetics specializing in women's and family health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

pharmaceutical companywomen's healthover-the-counterOTCnutritional supplementsmedical devicesgeneric drugsdermacosmeticsbiocidesmedical detailingpharma roll-upconsumer healthnutritherapypharmaceutical distribution

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceres Pharma Comparables

Compare Ceres Pharma with similar companies based on industry and business-model similarity.

Ceres Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Procare Health
80%
Surveal Laboratories
79%
Theramex
79%

Ceres Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingOct 6, 2022
DebtOct 1, 2021
Buyout/LBOJul 12, 2021

Key People

Founding team and executive leadership

Mario Debel

Executive Chairman & Founder, CEO & Founder

Founding Team

Mike Van Ganse

Chief Executive Officer

Executive Team

Anja Imschoot

CFO

Executive Team

Anna Rustioni

CFO Italy

Executive Team

Ceres Pharma Investors

Notable investors and investment history

Ceres Pharma investors
InvestorRounds
AlychloCorporate Funding
Barings BDCDebt
Naxicap PartnersBuyout/LBO
DovescoCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 51% MoM.

  • Feb 8, 2026

    Grew 32% QoQ, from 110 to 145 employees.

Ceres Pharma Filings

Explore SEC and related filing metadata, where available.

Ceres Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ceres Pharma's valuation, stock price, and market status.

Is Ceres Pharma a public or private company?

Ceres Pharma is a private company.

What is the current stock price of Ceres Pharma?

Ceres Pharma is a private company with no public stock price. Caplight tracks Ceres Pharma's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Ceres Pharma worth (valuation)?

Valuation information for Ceres Pharma is not publicly available.

Can I buy Ceres Pharma stock?

Ceres Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ceres Pharma's last funding round?

Ceres Pharma's most recent funding round was Corporate Funding on October 6, 2022.

Who are the main investors in Ceres Pharma?

Key investors in Ceres Pharma include Alychlo, Naxicap Partners.

Will Ceres Pharma IPO soon?

No public IPO plans have been announced for Ceres Pharma.

How can I track Ceres Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ceres Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range166
Year Founded2015
Last FundingOct 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?